CUHSR
The Committee on the Use of Human Subjects in Research (CUHSR) is charged with the review of research involving human subjects in order to protect those subjects. CUHSR assumes the duties of the IRB (Institutional Review Board) and ensures compliance with Federal Regulations regarding human subjects in research. CUHSR also will review some protocols involving human subjects that may not fall strictly within the scope of the federal definition of research. Some Quality Assurance/Improvement activities would fall into this category. Bradley University has Federal Wide Assurance which is an agreement with the Department of Health and Human Services to follow the federal regulations (45 CFR 46.103) for research that is conducted by or supported by a federal agency. These federal regulations serve as the bases for all processes and procedures conducted by the committee.
Any activity that meets the federal definitions of RESEARCH and HUMAN SUBJECTS requires IRB review.
Human Subject – means a living individual about whom an investigator (whether professional or student) conducting research:
- Obtains information or biospecimens through intervention or interaction with the individual, and uses, studies, or analyzes the information or biospecimens; or
- Obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens.
Research – means a systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge.
Levels of IRB Review
Human subjects research is review by Bradley’s IRB (CUHSR) under the following categories.
Exempt Review – Research can be approved as “exempt” if it is no more than “minimal risk” and fits one of the exempt review categories as defined by federal regulation 45 CFR 46. Studies that may qualify for “Exempt” must be submitted to the IRB for review.
Expedited Review – Research can be approved as “expedited” if it is no more than “minimal risk” and fits in one of the federally designated expedited review categories. Expedited reviews are conducted by a member of the IRB committee.
Full Board Review – Research that does not qualify for expedited or exempt review (presents more than minimal risks to subjects) will receive review at a fully convened IRB committee meeting.
CUHSR will review some projects that may be “Not Human Subjects Research” but may require approval with regard to ethical treatment of human subjects. Some quality assurance projects will fall into this category.
Bradley University uses an online system of application and protocol management called OneAegis. After August X, 2025, new applications must use the OneAgeis system. The old application will not be accepted. For protocols submitted prior to August X, 2025 continue to use the forms related to the old system.
To begin an application, you will go to https://bradley.oneaegis.com/. From here you will log on with your BUnetID used with the Single Sign On service.
Please go to the IRB Application Instructions [link to document] for detailed instructions regarding the initial application, the review process, modifications during the review, revisions of an approved protocol, protocol closure, continuing review, adverse event, and protocol management.
Expeditable Research
The general criteria for expedited review are that:
45 CFR 46.110 (b)(1) An IRB may use the expedited review procedure to review the following:
- Some or all of the research appearing on the list described in paragraph (a) of this section [see below], unless the reviewer determines that the study involves more than minimal risk; [45 CFR 46 102 9: Minimal risk means that the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests].
- Minor changes in previously approved research during the period for which approval is authorized; or
- Research for which limited IRB review is a condition of exemption under §46.104(d)(2)(iii), (d)(3)(i)(C), and (d)(7) and (8).
Adjunct List of Categories Qualifying for Expedited Review
Category 1
Clinical studies of drugs and medical devices only when condition (a) or (b) is met, (a) Research on drugs for which an investigational new drug application (21 CFR Part 312) is not required. (b) Research on medical devices for which (i) an investigational device exemption application (21 CFR Part 812) is not required; or (ii) the medical device is cleared/approved for marketing and the medical device is being used in accordance with its cleared/approved labeling.
Category 2
Collection of blood samples by finger stick, heel stick, ear stick, or venipuncture as follows: (a) from healthy, non-pregnant adults who weigh at least 110 pounds. For these subjects, the amounts drawn may not exceed 550 ml in an 8 week period and collection may not occur more frequently than 2 times per week; or (b) from other adults and children, considering the age, weight, and health of the subjects, the collection procedure, the amount of blood to be collected, and the frequency with which it will be collected. For these subjects, the amount drawn may not exceed the lesser of 50 ml or 3 ml per kg in an 8 week period and collection may not occur more frequently than 2 times per week.
Category 3
Prospective collection of biological specimens for research purposes by noninvasive means, Examples: (a) Hair and nail clippings in a non-disfiguring manner; (b) Deciduous teeth at time of exfoliation or if routine patient care indicates a need for extraction; (c) Permanent teeth if routine patient care indicates a need for extraction; (d) Excreta and external secretions (including sweat); and (e) uncannulated saliva collected either in an unstimulated fashion or stimulated by chewing gumbase or wax or by applying a dilute citric solution to the tongue; (f) Placenta removal at delivery; (g) Amniotic fluid obtained at the time of rupture of the membrane prior to or during labor; (h) Supra-and subgingival dental plaque and calculus, provided the collection procedure is not more invasive than routine prophylactic scaling of the teeth and the process is accomplished in accordance with accepted prophylactic techniques; (i) Mucosal and skin cells collected by buccal scraping or swab, skin swab, or mouth washings, (j) Sputum collected after saline mist nebulization.
Category 4
Collection of data through noninvasive procedures (not involving general anesthesia or sedation) routinely employed in clinical practice, excluding procedures involving x-rays or microwaves. Where medical devices are employed, they must be cleared/approved for marketing. (Studies intended to evaluate the safety and effectiveness of the medial device are not generally eligible for expedited review, including studies of cleared medical devices for new indications.) Examples: a) physical sensors that are applied either to the surface of the body or at a distance and do not involve input of significant amounts of energy into the subjects or an invasion of the subject’s privacy. (b) weighing or testing sensory acuity; (c) magnetic resonance imaging; (d) electrocardiography, electroencephalography, thermography, detection of naturally occurring radioactivity, electroretinography, ultrasound, diagnostic infrared imaging, Doppler blood flow, and echocardiography; (e) moderate exercise, muscular strength testing, body composition assessment, and flexibility testing where appropriate given the age, weight and health of the individual.
Category 5
Research involving materials (data, documents, records, or specimens) that have been collected for any reason or will be collected solely for nonresearch purposes (such as medical treatment or diagnosis)
Category 6
Collection of data from voice, video, digital, or image recordings made for research purposes.
Category 7
Research on group characteristics or behavior (including, but not limited to, research on perception, cognition, motivation, identity, language, communication, cultural beliefs, or practices, and social behavior or research employing survey, interview, oral history, focus group, program evaluation, human factors evaluation, or quality assurance methodologies.
Category 8
Continuing review of research previously approved by a convened IRB as follows: (a) where (i) the research is permanently closed to the enrollment of new subjects; (ii) all subjects have completed all research-related interventions; and (iii) the research remains active only for the long term follow-up of subjects; or (b) where no subjects have been enrolled and no additional risks have been identified or (c) where the remaining research activities are limited to data analysis.
Category 9
Continuing review of research not conducted under an investigational new drug application or investigational drug exemption where categories 2 through 8 do not apply but the IRB has determined and documented at a convened meeting that the research involves no greater than minimal risk and no additional risks have been identified.
Research Exempt from Full Review
(effective 21 JAN 2019)
Although the category is called “exempt,” this type of research does require the principle investigator to submit a CUHSR application. Only CUSHR can make the determination if a human subject research protocol is exempt from a full review and thus exempt from all the federal regulations regarding human subjects in research. The exempt review process is less rigorous than an expedited or full-committee review. To qualify, research must fall into one of eight (8) federally-defined exempt categories. These categories present the lowest amount of risk to potential subjects because, generally speaking, they involve either collection of anonymous, publicly-available or de-identified data, or the conduction of very benign behavioral research experiments. The exempt human subjects research must still be conducted in a manner that meets general ethical guidelines such as:
- The research has no or very little risk (many minimal risk studies may be considered under expedited review)
- The selection of participants is equitable
- Adequate provision are made to maintain the confidentiality of the data
- If there are interaction with participants, a consent process should be in place that discloses such information as:
- The activity involves research
- A description of the procedures and the nature of the information collected
- Participation is voluntary
- Adequate provisions to maintain the privacy of the participants
- Name and contact information for the researcher
Some of the following factors that may raise questions in the review whether a protocol is exempt or not:
- The protocol does not clearly fit into one of the exempt categories. The application should be written so that it is clear to the reviewer which category the research falls under.
- The data is not collected anonymously. Data is considered anonymous if there is not a link between participant identifiers and the data. The application should be very clear as to how the data is managed to be considered anonymous.
- Demographics information collected is so extensive such that individuals could be identified. The application should be clear whether demographics information is used to only describe the subject pool and not linked to the primary data, or if the (or which) demographics are variables of interest and linked to the data.
- The data collected is sensitive and if identified would put an individual at risk.
- The questions asked could be disturbing to the individual.
- If there were potential violations in collecting protected health information (HIPAA Privacy rule) or protected student information (FERPA).
- Vulnerable populations as subjects. Involving children, adults with impaired decision-making capacity, pregnant women and prisoners in research will in all likelihood required an expedited or full CUHSR review process.
The following are the eight categories exempt research specified by the Department of Health and Human services 45 CFR 46.104
Category 1 Exemption: Normal Educational Practices and Settings
Research, conducted in established or commonly accepted educational settings, that specifically involves normal educational practices that are not likely to adversely impact students’ opportunity to learn required educational content or the assessment of educators who provide instruction. This includes most research on regular and special education instructional strategies, and research on the effectiveness of or the comparison among instructional techniques, curricula, or classroom management methods.
Category 2 Exemption: Anonymous Education tests, Surveys, Interviews or Observations
Research that only includes interactions involving educational tests (cognitive, diagnostic, aptitude, achievement), survey procedures, interview procedures, or observation of public behavior (including visual or auditory recording) if at least one of the following criteria is met:
- The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained, directly or through identifiers linked to the subjects;
- Any disclosure of the human subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement, or reputation; or
- The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers linked to the subjects, and an IRB conducts a limited IRB review to make the determination required by §46.111(a)(7) [When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data]. (For item iii CUHSR is likely to ask that these types of studies undergo expedited review).
Category 3 Exemption: Benign behavioral interventions
- Research involving benign behavioral interventions in conjunction with the collection of information from an adult subject through verbal or written responses (including data entry) or audiovisual recording if the subject prospectively agrees to the intervention and information collection and at least one of the following criteria is met:
- The information obtained is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained, directly or through identifiers linked to the subjects;
- Any disclosure of the human subjects’ responses outside the research would not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects’ financial standing, employability, educational advancement, or reputation; or
- The information obtained is recorded by the investigator in such a manner that the identity of the human subjects can readily be ascertained, directly or through identifiers linked to the subjects, and an IRB conducts a limited IRB review to make the determination required by §46.111(a)(7) [When appropriate, there are adequate provisions to protect the privacy of subjects and to maintain the confidentiality of data]. (For item iii CUHSR is likely to ask that these types of studies undergo expedited review).
- For the purpose of this provision, benign behavioral interventions are brief in duration, harmless, painless, not physically invasive, not likely to have a significant adverse lasting impact on the subjects, and the investigator has no reason to think the subjects will find the interventions offensive or embarrassing. Provided all such criteria are met, examples of such benign behavioral interventions would include having the subjects play an online game, having them solve puzzles under various noise conditions, or having them decide how to allocate a nominal amount of received cash between themselves and someone else.
- If the research involves deceiving the subjects regarding the nature or purposes of the research, this exemption is not applicable unless the subject authorizes the deception through a prospective agreement to participate in research in circumstances in which the subject is informed that he or she will be unaware of or misled regarding the nature or purposes of the research.
Category 4 Exemption: Secondary Research for which consent is not required
Secondary research uses of identifiable private information or identifiable biospecimens, if at least one of the following criteria is met:
- The identifiable private information or identifiable biospecimens are publicly available;
- Information, which may include information about biospecimens, is recorded by the investigator in such a manner that the identity of the human subjects cannot readily be ascertained directly or through identifiers linked to the subjects, the investigator does not contact the subjects, and the investigator will not re-identify subjects;
- The research involves only information collection and analysis involving the investigator’s use of identifiable health information when that use is regulated under 45 CFR parts 160 and 164, subparts A and E, for the purposes of “health care operations” or “research” as those terms are defined at 45 CFR 164.501 or for “public health activities and purposes” as described under 45 CFR 164.512(b); or (iv) The research is conducted by, or on behalf of, a Federal department or agency using government-generated or government-collected information obtained for nonresearch activities, if the research generates identifiable private information that is or will be maintained on information technology that is subject to and in compliance with section 208(b) of the E-Government Act of 2002, 44 U.S.C. 3501 note, if all of the identifiable private information collected, used, or generated as part of the activity will be maintained in systems of records subject to the Privacy Act of 1974, 5 U.S.C. 552a, and, if applicable, the information used in the research was collected subject to the Paperwork Reduction Act of 1995, 44 U.S.C. 3501 et seq.
Category 5 Exemption: Public Benefit or Service Program
Research and demonstration projects that are conducted or supported by a Federal department or agency, or otherwise subject to the approval of department or agency heads (or the approval of the heads of bureaus or other subordinate agencies that have been delegated authority to conduct the research and demonstration projects), and that are designed to study, evaluate, improve, or otherwise examine public benefit or service programs, including procedures for obtaining benefits or services under those programs, possible changes in or alternatives to those programs or procedures, or possible changes in methods or levels of payment for benefits or services under those programs. Such projects include, but are not limited to, internal studies by Federal employees, and studies under contracts or consulting arrangements, cooperative agreements, or grants. Exempt projects also include waivers of otherwise mandatory requirements using authorities such as sections 1115 and 1115A of the Social Security Act, as amended.(i) Each Federal department or agency conducting or supporting the research and demonstration projects must establish, on a publicly accessible Federal Web site or in such other manner as the department or agency head may determine, a list of the research and demonstration projects that the Federal department or agency conducts or supports under this provision. The research or demonstration project must be published on this list prior to commencing the research involving human subjects.
Category 6 Exemption: Taste and Food Evaluation and Acceptance Studies
Taste and food quality evaluation and consumer acceptance studies:
- If wholesome foods without additives are consumed, or
- If a food is consumed that contains a food ingredient at or below the level and for a use found to be safe, or agricultural chemical or environmental contaminant at or below the level found to be safe, by the Food and Drug Administration or approved by the Environmental Protection Agency or the Food Safety and Inspection Service of the U.S. Department of Agriculture.
Category 7 Exemption: Storage or maintenance for secondary research for which broad consent is required
Storage or maintenance of identifiable private information or identifiable biospecimens for potential secondary research use if an IRB conducts a limited IRB review and makes the determinations required by §46.111(a)(8).
Category 8 Exemption: Secondary research for which broad consent is required
Research involving the use of identifiable private information or identifiable biospecimens for secondary research use, if the following criteria are met:
- Broad consent for the storage, maintenance, and secondary research use of the identifiable private information or identifiable biospecimens was obtained in accordance with §46.116(a)(1) through (4), (a)(6), and (d);
- Documentation of informed consent or waiver of documentation of consent was obtained in accordance with §46.117;
- An IRB conducts a limited IRB review and makes the determination required by §46.111(a)(7) and makes the determination that the research to be conducted is within the scope of the broad consent referenced in paragraph (d)(8)(i) of this section; and (iv) The investigator does not include returning individual research results to subjects as part of the study plan. This provision does not prevent an investigator from abiding by any legal requirements to return individual research results.
Criteria for CUSHR Approval of Research
CUHSR reviews and has the authority to approve, require modification (to receive approval) or disapprove all research activities covered by HHS guidelines. In order to approve a research project, CUHSR shall determine that all of the following requirements are satisfied (from 45 CFR 46.111):
- Risks to the subjects are minimized.
- Risks to the subjects are reasonable in relation to anticipated benefits, if any, to the subjects, and the importance of the knowledge that may be reasonably expected to result.
- Selection of subjects is equitable.
- Informed consent will be sought from each prospective subject or the subject’s legally authorized representative.
- Informed consent will be appropriately documented or appropriately waived.
- When appropriate, the research plan make adequate provision for monitoring the data collected to ensure the safety or subjects.
- Where appropriate, there are adequate provisions to protect privacy of subjects and to maintain the confidentiality of data.
- Broad consent for storage, maintenance and secondary research use of identifiable private information or identifiable biospecimens is obtained.
- Where some or all of the subjects are likely to be vulnerable to coercion or undue influence, such as children, prisoners, individual with impaired decision-making capacity or economically or educationally disadvantaged persons, additional safeguards have been included in the study to protect the rights and welfare of these subjects.
CUHSR shall have the authority to suspend or terminate approval of research that is not being conducted in accordance with its requirements or that has been associated with unexpected serious harm to subjects.
CUHSR regulations require that research involving any level of deception be followed by an appropriate debriefing of all subjects. Debriefing procedures should be specified in the CUHSR application form.
Not Human Subjects Research and Quality Assurance Projects
The area of QA/QI and human subjects review has been controversial and unclear for many institutions. The confusion arises because QA/QI activities and research activities both use scientific methods, however, most QA/QI projects do not fall squarely into the definition of human subject research as established by the federal regulations thus making it technically exempt from review by an IRB. QA/QI projects are typically management activities collecting and analyzing data to assess some internal operation for monitoring and improvement purposes. These activities typically do not attempt to be systematic about subject selection related to a population. Nor do QA/QI projects try to make broad inferences (generalize) beyond the scope of the institution. Thus QA/QI typically falls outside the regulatory definition of research which states: “Research means a systematic investigation, including research development, testing, and evaluation, designed to develop or contribute to generalizable knowledge.” 45CFR46.102(l). Research tends to be an investigation with a question or hypothesis driving the activity. The answer to the question is typically interpreted broadly and inferences are made beyond the sample.
Many QA/QI projects involve interactions or interventions with human subjects. Though a project may not be technically “research,” it might involve human subjects. An institution, such as Bradley University, still has a duty in assuring human protections and follows certain ethical principles and guidelines as it applies to all investigations involving human subjects with interactions, interventions or collecting personal information. Bradley University is committed to follow the guidelines of the Belmont report. The three ethical concepts in the Belmont report are 1) respect for persons, 2) beneficence, and 3) justice. Thus, in the application of these principles, protocols are carefully considered with regard to informed consent, privacy of personal information, risk benefit assessment, and selection of subjects. These principles should be applied to all investigations involving human subjects even if that project technically is exempt or falls outside of the technical definitions of the federal regulations. QA/QI projects involving human subjects with interactions or interventions or collecting personally identifiable information (and biospecimens) should follow ethical principles. The question remains whether these projects should be reviewed by CUHSR.
What types of QA/QI projects DO NOT need CUHSR review?
- A project that is not research (by the federal definition) and does not involve human interaction, intervention or the collection of personal information does not need a review. An example would be if an individual is looking at de-identified data for the purpose of assessing an internal process or quality factor. The only caveat would be in a setting where there are additional privacy laws and procedures such as in health care and higher education. The project leader may have to pass their project through a local privacy board or privacy official.
- A project that is not research (by the federal definition) but involves a benign human interaction would not need a review. For example, an anonymous, voluntary survey assessing the effectiveness of a single workshop within the institution would typically not need a review. Anonymous surveys done by students as a class project within the institution would typically not need to be reviewed, as long as they are not collecting personal and sensitive information, or as long as they would not consider inferring the results of their data analysis broadly. Likewise, a teacher collecting anonymous information on a class to assess their teaching effectiveness would not need a review. By design the risk is negligible and the focus is internal with an intent to benefit those who are participating.
- A project that is not research (by the federal definition) but involves a human interaction, but is carried out by individuals who are familiar with ethical standards would not need a review. A consultant conducting surveys for an employer might fall into this group. Though the methodology may look like high quality research, the intent is never to share the results outside the confines of that specific group. The intent is to improve a program, practice or process of a specific institution. The intent is not to contribute to generalizable knowledge. Customer satisfaction surveys might fall into this category as well. There is an expectation that the survey would be conducted using ethical standards such as it being confidential, voluntary and involves a consent process. In this case like this, CUHSR is willing to give guidance on ethical conduct if needed.
What types of QA/QI project need a review?
Technically, if it is clearly a QA/QI project, it does not need an IRB review according to the federal regulations. However, there are cases where we as an institution would highly recommended and in some cases, require that project be reviewed. When in doubt, it is always good to fill out an application and have your project reviewed.
- If the project collects personal information that is sensitive or that a breach in confidentiality might put the subjects at risk, then a review should occur. For example, a survey asking about employee behavior could cause reputational damage should the information be shared. A survey asking students about sexual abuse on campus would be considered sensitive and thus would need a CUSHR review.
- If the project introduces an intervention that could potentially introduce some risk might need a review. For example, a project leader may want to introduce a new behavioral modification system for agitated patients with dementia and assess its effectiveness within the institution. This type of project potentially has several ethical pitfalls such as a) does the intervention have sound scientific background, b) how will the participants give consent considering that they may be impaired in decision making, and c) how will the confidentiality of the data be maintained. Having it reviewed could help avoid any ethical violations. It is a good practice to submit an application for review for any QA/QI project that involves an intervention of some sort.
- Some projects may need to be reviewed if they involve protected health information. Even if it is QA/QI, HIPAA standards need to be followed. It may take a review in order to determine that no HIPAA regulations are being broken.
- If your QA/QI project is funded, the funding source may require a human subject review and approval before it can move forward. The breath of the committee charge will allow CUHSR to approve it as “Not human subject research.”
- The Scholarship of Teaching and Learning (SOTL) research need a review. A SOTL activity might be looking an internal assessment process or a brief intervention in a classroom with the intent of improving teaching practice. However, the ordinary intent of SOTL research is to disseminate the findings in order to contribute to evidence based practice of teaching in general.
What types “research” projects DO NOT need a review?
If a project meets the definition of research and human subject interaction by the federal guidelines, then it need an IRB review. Occasionally projects are set up like research (hypothesis driven) yet there is clearly not an intent to share the results with the purpose of contributing to generalizable knowledge. The case where this happens the most is in undergraduate research classes. As part of the class, the students may be asked to conduct “research” that involves human subjects in a low risk activity, but there is not an intent that the results are disseminated beyond that class (or department). In this case, the instructor is the one responsible that the projects are carried out following ethical principles. CUHSR is more than willing to assist instructors in understanding human subject’s review process. All our review procedures and forms are available to use by the instructor and class in order to simulate an actual review. Ethical training (CITI) is available for anyone on campus. If the projects are being disseminated beyond the department, including the Bradley Student Expo, then a CUHSR review needs to occur prior to collecting data on human subjects.
What if I am not sure if I have a QA/QI project or if it is research?
Often the intent of your project is what determines whether it is research or not. So, if you are assessing an existing process with no intent to share the results broadly and with the intent to assess or improve the process, then this is clearly a QA/QI project. In this case there is no research question or hypothesis and no intent to contribute to generalizable knowledge. In doing a similar project, you might assess a process with the intent of determining the variables that affect that process, so that this could be shared broadly to contribute to the general knowledge of that process. This has the appearance of research and needs to be reviewed if it involves human subjects. When the purpose of the project is stated on the application, research intent should be clear in that brief statement. When there is a doubt, you should submit an application to CUHSR.
Can I publish or present my QA/QI project?
Yes, you can – but please note, if you are doing QA/QI it would be unlawful to refer to it as research as this implies that it meets the federal definition of research as was approved by an IRB under the federal guidelines. Intent to disseminate results is not the criteria for something to be consider research and thus require a prospective review. Some QA/QI projects are worthy of dissemination broadly, but if they are disseminated, the authors should state clearly the intent as QA/QI and not research. If your ultimate intent is to publish or have your work disseminated, we might recommend that you adapt your project to reflect research and have it reviewed. Many journals will not accept a paper unless there was proof that it was approved by an IRB.
Once I collect data on a QA/QI project that was not approved by CUHSR, can I go back and get approval of the project as research?
ZOnce an investigation is conducted and the data is collected under QA/QI an investigator cannot change the status of their study by getting it approved as research by an IRB. The federal regulations make no provision for a retrospective review. The regulations are clear that approval of research is prospective. CUHSR recommends that you think that you might have a QA/QI project that many have results that could make a contribution to generalizable knowledge, then the investigator should seek IRB approval of the project as research before it commences. In some cases, a project might have a dual purpose to evaluate an internal process and evaluate the result in a broader context. If this is the case then the project should be reviewed prospectively as research.
Some QA/QI projects may involve personal information, such as a GPAs, or salaries, however if that information is collected in such a way that the data cannot be tracked to an identifiable person and the project does not involve interaction with individuals, then it would not necessarily need a review. This scenario may be another mater in areas where there are additional protections on personal data, such as in health care (HIPAA or FERPA). In a health care setting or an educational setting, a review should occur so there are assurances that no HIPAA or FERPA violations have occurred. When in doubt, the investigator should contact the CUHSR chair or their immediate supervisor.
The type of interaction or intervention will also dictate the need for a review. As previously mentioned, an anonymous survey with the intent to look at an internal process and that does not collect sensitive or personal information may not need a review. However, if you survey the effectiveness of an intervention and that intervention has some risk or the population was inherently at risk, then is should be reviewed. For example, if you are a Bradley student and want to determine the effectiveness of community exercise program that brings in people who may not ordinarily exercise, then this should be reviewed because these people may be at risk of harm from your intervention. This should be reviewed even if your intent is not to broadly interpret the results. Also, if your survey has sensitive questions that might disturb or upset the participants, or if a breach of confidentiality would bring harm, then it should be reviewed.
IRB/CUHSR Application and Review | Characteristic of investigation |
NO | Most QA/QI investigations Most QA/QI investigations No Human Interaction, Intervention, or collection of identifiable information. Not Research (Not systematic or intent to be generalizable). Example: De-identified data used to evaluate internal processes or status (Health care settings may need approval of CUHSR or Privacy board) |
NO | Many QA/QI investigations Begin Human Interaction, Intervention or collection of de-identified information. Not Research (Not systematic or intent to be generalizable). Example: Anonymous survey about effectiveness of a workshop Class survey about teaching effectiveness (Any human interaction should still have a voluntary consent process). |
YES | Some QA/QI investigations – Gray zone Human Interaction, intervention or collection of identifiable information. Not research (not systematic or intent to be generalizable). Example: Anonymous survey about a deliberate change in process that may involve some risk (even if minor) to subject. Anonymous survey about a sensitive subject. A survey that collects identifiable information. This may be QA/QI but will be approved under the standards of research by CUHSR. |
YES | Appears to be QA/QI but intent is research No Human Interaction, Intervention, or collection of identifiable information. Research (systematic with intent to be generalizable). Example: Retrospective review of a de-identified data base. Very likely to be reviewed as Exempt research. |
YES | Reviewed as Research Human Interaction, intervention or collection of identifiable information. Research (systematic with intent to be generalizable). Example: All other investigations reviewed under the federal regulations. |
General Requirements of Informed Consent
The following applies for studies reviewed under an expedited review process and a full review process. View the forms below.
(From 45 CFR 46.116) (a) No investigator may involve a human being as a subject in research covered by these regulations unless the investigator has obtained the legally effective informed consent of the subject or the subject’s legally authorized representative. An investigator shall seek such consent only under circumstances that provide the prospective subject or the representative sufficient opportunity to consider whether or not to participate and that minimize the possibility of coercion or undue influence. The information given to the subject or the representative shall be in language understandable to the subject or the representative. The subject or representative must be provided with information that a reasonable person would want to have in order to make an informed decision about whether to participate and an opportunity to discuss that information. Informed consent must begin with a concise and focused presentation of key information to assist in understanding the reasons why one may or may not participate. As a whole, the informed consent must present information in sufficient detail and must be organized to facilitate the subject’s or representative’s understanding or the reasons to one might or might not want to participate. No informed consent, whether oral or written, may include any exculpatory language through which the subject or the representative is made to waive or appear to waive any of the subject’s legal rights, or releases or appears to release the investigator, the sponsor, the institution, or its agents from liability for negligence.
Basic elements of informed consent shall include the following:
- A statement that the study involves research, an explanation of the purposes of the research and the expected duration of the subject’s participation, a description of the procedures which are experimental;
- A description of any reasonably foreseeable risks or discomforts to the subject;
- Description of any benefits to the subjects or to others which may reasonably be expected from the research;
- A disclosure of appropriate alternative procedures or courses of treatment, if any, that might advantageous to the subject
- Statement describing the extent, if any to which confidentiality of records identifying the subject will be maintained;
- For research involving more than minimal risk, an explanation as to whether any compensation and an explanation as to whether any medical treatments are available if injury occurs and, if so what they consist of or where further information may be obtained
- An explanation of whom to contact for answers to pertinent questions about the research and research subjects’ rights, and whom to contact in the event of research-related injury to the subject
- A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits to which the subject is otherwise entitled.
- One of the following statements about any research that involves the collection of identifiable private information or identifiable biospecimens: (i) A statement that identifiers might be removed from the identifiable private information or identifiable biospecimens and that, after such removal, the information or biospecimens could be used for future research studies or distributed to another investigator for future research studies without additional informed consent from the subject or the legally authorized representative, if this might be a possibility; or
- A statement that the subject’s information or biospecimens collected as part of the research, even if identifiers are removed, will not be used or distributed for future research studies.
Where appropriate, the following elements of informed consent must also be included:
- A statement that the particular treatment or procedure may involve risks to the subject which are currently unforeseeable;
- Anticipated circumstances under which the subject’s participation may be terminated by the investigator without regard to the subject’s consent;
- Any additional costs to the subject that may result from participation in the research;
- The consequences of a subject’s decision to withdraw from the research and procedures for orderly termination of participation by the subject;
- A statement that significant new findings developed during the research which may relate to the subject’s willingness to continue participation will be provided to the subject; and
- A statement that the subject’s biospecimens (even if identifiers are removed) may be used for commercial profit and whether the subject will or will not share in this commercial profit
- A statement regarding whether clinically relevant research results, including individual research results, will be disclosed to subjects, and if so, under what conditions
- For research involving biospecimens, whether the research will (if known) or might include whole genome sequencing (i.e., sequencing of a human germline or somatic specimen with the intent to generate the genome or exome sequence of that specimen)
Elements of broad consent for the storage, maintenance, and secondary research use of identifiable private information or identifiable biospecimens
Broad consent for the storage, maintenance, and secondary research use of identifiable private information or identifiable biospecimens (collected for either research studies other than the proposed research or nonresearch purposes) is permitted as an alternative to the informed consent requirements in paragraphs (b) and (c) of this section. If the subject or the legally authorized representative is asked to provide broad consent, the following shall be provided to each subject or the subject’s legally authorized representative:
- The information required in paragraphs (b)(2), (b)(3), (b)(5), and (b)(8) and, when appropriate, (c)(7) and (9) of this section;
- A general description of the types of research that may be conducted with the identifiable private information or identifiable biospecimens. This description must include sufficient information such that a reasonable person would expect that the broad consent would permit the types of research conducted
- A description of the identifiable private information or identifiable biospecimens that might be used in research, whether sharing of identifiable private information or identifiable biospecimens might occur, and the types of institutions or researchers that might conduct research with the identifiable private information or identifiable biospecimens;
- A description of the period of time that the identifiable private information or identifiable biospecimens may be stored and maintained (which period of time could be indefinite), and a description of the period of time that the identifiable private information or identifiable biospecimens may be used for research purposes (which period of time could be indefinite);
- Unless the subject or legally authorized representative will be provided details about specific research studies, a statement that they will not be informed of the details of any specific research studies that might be conducted using the subject’s identifiable private information or identifiable biospecimens, including the purposes of the research, and that they might have chosen not to consent to some of those specific research studies;
- Unless it is known that clinically relevant research results, including individual research results, will be disclosed to the subject in all circumstances, a statement that such results may not be disclosed to the subject; and
- An explanation of whom to contact for answers to questions about the subject’s rights and about storage and use of the subject’s identifiable private information or identifiable biospecimens, and whom to contact in the event of a research-related harm.
CUHSR has the authority to approve a consent procedure which does not include or which alters some or all of the previously mentioned elements of informed consent or waive the requirements for informed consent if, either
- The research involves no more than minimal risk to the subjects;
- The research could not practicably be carried out without the requested waiver or alteration;
- If the research involves using identifiable private information or identifiable biospecimens, the research could not practicably be carried out without using such information or biospecimens in an identifiable format;
- The waiver or alteration will not adversely affect the rights and welfare of the subjects; and
- Whenever appropriate, the subjects or legally authorized representatives will be provided with additional pertinent information after participation.
Or the research or demonstration project is to be conducted by or subject to the approval of state or local government officials and is designed to study, evaluate, or otherwise examine
- Public benefit or service programs;
- Procedures for obtaining benefits or services under those programs;
- Possible changes in or alternatives to those programs or procedures; or
- Possible changes in methods or levels of payment for benefits or services under those programs; and the research could not practicably be carried out without the waiver or alteration.
If an individual was asked to provide broad consent for the storage, maintenance, and secondary research use of identifiable private information or identifiable biospecimens in accordance with the requirements at paragraph (d) of this section, and refused to consent, an IRB cannot waive consent for the storage, maintenance, or secondary research use of the identifiable private information or identifiable biospecimens.
Documentation of Informed Consent
(From 45 CFR 46.117) (a) Informed consent shall be documented by the use of a written consent form approved by CUHSR and signed (including in an electronic format) by the subject or the subject’s legally authorized representative. A copy shall be given to the person signing the form. See forms for a model consent form.
(b) The informed consent form may be either of the following:
- A written informed consent form that meets the requirements of §46.116. The investigator shall give either the subject or the subject’s legally authorized representative adequate opportunity to read the informed consent form before it is signed; alternatively, this form may be read to the subject or the subject’s legally authorized representative.
- A short form written informed consent form stating that the elements of informed consent required by §46.116 have been presented orally to the subject or the subject’s legally authorized representative, and that the key information required by §46.116(a)(5)(i) was presented first to the subject, before other information, if any, was provided. The IRB shall approve a written summary of what is to be said to the subject or the legally authorized representative. When this method is used, there shall be a witness to the oral presentation. Only the short form itself is to be signed by the subject or the subject’s legally authorized representative. However, the witness shall sign both the short form and a copy of the summary, and the person actually obtaining consent shall sign a copy of the summary. A copy of the summary shall be given to the subject or the subject’s legally authorized representative, in addition to a copy of the short form.
(c1) An IRB may waive the requirement for the investigator to obtain a signed informed consent form for some or all subjects if it finds any of the following:
- That the only record linking the subject and the research would be the informed consent form and the principal risk would be potential harm resulting from a breach of confidentiality. Each subject (or legally authorized representative) will be asked whether the subject wants documentation linking the subject with the research, and the subject’s wishes will govern;
- That the research presents no more than minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of the research context; or
- If the subjects or legally authorized representatives are members of a distinct cultural group or community in which signing forms is not the norm, that the research presents no more than minimal risk of harm to subjects and provided there is an appropriate alternative mechanism for documenting that informed consent was obtained.
(c2) In cases in which the documentation requirement is waived, the IRB may require the investigator to provide subjects or legally authorized representatives with a written statement regarding the research.
If investigators are not obtaining a signature, then a waiver with a rationale must be requested on the application. Electronic signatures are those that legally verifiable. “Click if you Agree” is a good practice, but does not constitute a signature.
It is the responsibility of the investigator (faculty member, administrator, or student) using human subjects in a covered research project to submit the appropriate application materials for Committee review according to the following guidelines:
- Complete the application form and an appropriate informed consent form.
- Submit all completed forms to cuhsr@fsmail.bradley.edu. After August X, 2025, us the OneAegis System. During the current academic year, the Committee will meet monthly. Application materials must be submitted by 11:00 a.m. on the Wednesday one week prior to the meeting. Expedited and Exempt review will occur on an ongoing basis and can be submitted anytime.
- Written (email) responses concerning Committee action and/or approval forms will be sent to the applicant within one week following final action by the Committee.
- The Committee reserves the right to consult with the subject matter, medical, or legal experts concerning any projects submitted for review. If expert review of a proposal is deemed necessary by the Committee, a substantial delay in Committee action should be anticipated.
- If a project is denied approval by the Committee, the applicant will be notified in writing of the reasons for disapproval and will be given the opportunity to respond in person or in writing.
- All research projects that have been approved by the Committee may be subject to further review or disapproval by appropriate officials of the University. Projects that have been disapproved by the Committee may not be subsequently approved by any other University’s Officer.
- Major changes in the research design and/or procedures following Committee approval must be resubmitted to the Committee as an amended proposal. In addition, progress reports must be submitted at least annually and more often if so specified by the Committee.
- Approval of a project does not remove the researcher’s legal responsibility for the project. The researcher is expected to retain signed individual informed consent forms for a period of five years. The Committee’s approval of a project constitutes only a statement by the Bradley Committee that it believes the rights of human beings will be adequately protected.
- Questions concerning application procedures and guidelines should be referred to the Chairperson of CUHSR.
Final Status and Protocol Closure
When a protocol in finished the Principal Investigators have the responsibility of informing CUSHR when a protocol has been completed. This requirement is for any study that initially approved by CUHSR and includes studies approved by full review, expedited review, exempt studies and quality assurance studies.
Investigator should submit a Final Status and Protocol Closure form to the CUSHR office via email to cuhsr@fsmail.bradley.edu at the conclusion of their study OR use the Protocol closure from on OneAegis if the protocol was submitted by OneAegis. Forms can be found on the CUSHR website or by login on OneAegis. As a reminder, investigators will be notified by CUHSR shortly after to the anticipated time they stated they would be finished with their data collection or at least annually one month before the anniversary of the initial approval. Those studies with Full Committee Review that are ongoing should fill out a Continuing Review form.
Faculty advisors for student research are responsible to ensure that the Final Status and Protocol Closure Report is filed with CUHSR in a timely fashion. A protocol may be closed when ALL of the following apply:
- All subject recruitment and enrollment is complete (i.e., no new subject recruitment or enrollment are ongoing)
- All subject specimens, records, data have been obtained (i.e., no further collection of data/information from or about living individuals will be obtained)
- No further contact with subjects is necessary (i.e., all interactions or interventions are complete and no further contact with enrolled subjects is necessary)
- Analysis of subject identifiable data, records, specimens are complete (i.e., use or access to subject identifiable data is no longer necessary)
The completed Final Status and Protocol Closure form should be submitted it to CUHSR within 30 days of closure of the protocol.
Should a principal investigator terminate employment from Bradley University, he or she must either submit a Final Status form or formally transfer the protocol to another principal investigator via a modification which is reviewed and approved by the CUHSR. In very rare cases, the CUHSR may grant special permission for the departing individual to remain as principal investigator on the protocol. Cases are reviewed on a case-by-case basis.
The Scholarship of Teaching and Learning (SOTL) is a growing area of research. Conducting research on one’s own teaching methods or student behaviors in a classroom is a rewarding line of research, but it can be fraught with ethical and legal pitfalls. SOTL research usually involves intervention or interaction with students and thus falls under the review of the Committee on the Use of Human Subjects in Research (CUHSR or Bradley’s IRB). In addition to human subject interaction or intervention, reviewable research typically deploys a methodology that is systematic and generates results that are generalizable. This means that there is a purpose and hypothesis related to the data collection (systematic) and the data will be analyzed in such a way as to make some inferences beyond the immediate subjects of the research (generalizable). This usually implies an intent to publish or disseminate the outcomes. This type of research must be approved by CUHSR.
FERPA and Research
An important area to consider in SOTL research is the Family Educational Rights and Privacy Act (FERPA), which is a federal law that protects the privacy of student education records. The provisions of the act must be followed when researchers are using student data in their research. The main concern regarding FERPA when doing research is accessing student education records and data without permission or consent. Generally, student education records are confidential and may not be released without written consent from the student. Student educational records are any materials that contain information related to a student and are maintained by the institution. Examples of educational records include graded materials (exams, papers), class rosters, transcripts, and computer screen data. There are exceptions to obtaining consent under FERPA. Please see the Office of the Registrar website for more information and details. (The details of the exceptions can be found in the Federal Register 34 CFR § 99.31.)
SOTL research tends to fall into several broad categories regarding the type of data collected. First is institutional student data, such as ACT/SAT scores or course grades. Another type of student data is generated through normal classroom activities, such as test and assignment grades. These data sets would squarely fall under the FERPA regulations. Finally, there is research data that is collected through the activity of the researcher apart from the course activity, such as a survey. Each of these areas will be discussed.
If your research involves intuitional data, which is data that is officially housed by the Office of the Registrar and is accessible to you, then, if you have demonstrated a legitimate educational interest, you may access that information according to the CUHSR-approved protocol. CUHSR will be looking for 1. a clear legitimate educational interest (defined above), 2. that you will de-identify the data as soon as you can in the process, and 3. that only those on the research team that are Bradley employees who have an educational interest can see the identified data. You will also need to specify in the application the specific data, the time frame of the data, and the specific purpose of the data related to your research and to whom the data would be released to. You will need to carefully describe how you will keep the data confidential and private. Should you need data that is not already accessible to you, you will need to make that request with the appropriate departments. Typically this request can be initiated from the Office of Institutional Effectiveness through a request form. Typically, this data would be released in a de-identified form.
The following content is needed in the consent form about student information:
- The specific records or information collected. The requested information should be specified by item (for example, in course ENG 101 assignment on…, final course grade, and exams 1and 2). You cannot request the entire academic record of the course. It must be specific to the research question.
- The specific time frame in the data is collected (fall semester 2020 in which you are currently enrolled).
- The specific purpose of the data should be clear. You should not collect information that does not directly relate to your research project.
- To whom the data is released. This should be to just the professor or the investigator who will de-identify the data.
- The consent must include the signature of the student or if under 18, a signature of a parent or legally authorized representative. This should be a written signature or a verifiable electronic signature. Should a student not provide consent to use their data, the researcher is not allowed to use it in their research.
Other FERPA Concerns in Research
Faculty are not allowed to give out a class roster so that a researcher can recruit subjects from that list. This would be a FERPA violation.
Researchers not affiliated with Bradley may not access identifiable student data without permission even though their research may seem to fall under a “legitimate educational interest.” The interest is only legitimate for those within the institution.
Students who are researchers typically do not have a “legitimate educational interest” and thus cannot have access to student information without a FERPA release.
Other Educational (SOTL) Research Not Under FERPA
During normal operations, you can “evaluate” the students’ activities, scores, and metrics without their consent where you have a “legitimate educational interest” within your direct responsibilities at the institution (such as within your course or unit). This is not considered “research” by federal regulations. Nor is it a violation of FERPA if the data is kept internally with those that share the educational interest or if the data is de-identified. However, if you are doing “human subjects research” with the intent to analyze and disseminate the data, then you must have the student’s written consent. This is true even if you de-identify the data after you receive it. If you need data from students that are typically institutional data you might consider asking the student to self-report that data, such as a self-reported ACT/SAT score, current GPA, and demographic information. In this case, in your dissemination, you would need to be clear that this data was self-reported.
SOTL Research Not Involving Student Data
Some SOTL research will ask students to do something that is outside the normal classroom activity. A good example is a pre and post survey to determine the perceptions of the student on the effectiveness of a certain educational intervention. This survey would have nothing to do with education occurring in the classroom. Since it is not a part of the normal class, the data gathered is not “student data” and FERPA does not apply. When doing this activity certain elements must be clear (and these apply in principle when also using student course data – see sample consent forms):
- The activity is voluntary and the student’s participation or non-participation will not impact the student’s grade or standing in the class.
- If an incentive is given, such as extra credit points, then the researcher must give a non-research opportunity with a similar incentive, such as a brief assignment. Thus, the individual who voluntarily does not wish to participate in research has the same opportunity to gain extra credit points. An element of coercion would exist without this non-research alternative.
- The students should be explicitly told that the professor/researcher will be blinded to who will participate until the final grade is posted. Thus, students will not have the perception that their grades could be unduly influenced by their participation. Typically, SOTL researchers, if collecting student data and thus collecting signed written consent forms, will have a confidant who is not associated with the research but who is knowledgeable about the research pass out and collect the consent forms, and then hold the forms until the final grade is posted. It would be difficult for the professor to collect the signed forms in a blind fashion.
A couple of alternative situations may be present. If you are collecting survey data that is not part of the class (thus not student data), you could use electronic consent where no identifiers are used. Typically, they will click on an “I agree to participate” box or button which takes them to the survey without providing identifiers. This is an acceptable practice when the primary risk of the research would be a breach of confidentiality. If doing this, you should request a “waiver of documentation of consent” on the CUHSR application form. In cases of pre and post-data, another researcher, who is not the main professor, could match up pre and post-data and then de-identify data so that the professor is blinded. Qualtrics can also provide a unique code to a participant that they can use to take a post survey. The pre and post surveys are de-identified but can be matched by the unique codes.
SOTL Research Confidentiality
Privacy, confidentiality, and data protection are always concerns. Anonymity is the highest level of privacy, and this occurs when there is no link to any identifier to the data at any time in the research process. A survey sent electronically with no identifiers collected would be considered anonymous. Anonymity implies that the researcher is never able to identify the participants and any point. Confidentiality relates to the efforts by the researcher to protect the identity of participants. A good example of a confidentiality practice is to de-identify the data and replace it with a unique code early in the process. Re-identification can sometimes be an issue. This can happen when detailed demographics are collected in such a way that an individual can be identified. For example, suppose your data set contains information such as gender, race, class, zip code, and an activity, then the person could be identifiable by this data set (for example – an individual who identifies as a Hispanic female who is a sophomore volleyball player from zip code 61606 – based on this information the participant could be identified). Therefore, you should explain how each variable relates to your research, that is state how each demographic variable relates to your research question. Or you can state that your demographic data will be disassociated from the other research variables in the data set and demographics are only dealt with in aggregate to describe your participants. Describing your participants in this way is sometimes a requirement of publication. Typically, the data set should be de-identified in such a way that if a third party were to look at the data set, they could not see or formulate the identity of any participant. Detailed handling of the data confidentiality will need to be explained in the CUHSR application and in the consent form.
Most SOTL research is very low risk and likely will fall into an EXEMPT category. EXEMPT means that the research is exempt from the stringent federal regulations of human protection in research. Exempt research must fall squarely into one of the exempt categories and only CUHSR can make this determination. Risk will rise in SOTL research projects when a breach of confidentiality could harm the student’s reputation, financial standing, or employability. CUSHR will also consider research that may cause emotional distress or embarrassment. In these cases, extra steps will need to be taken to inform the individual of the level of risk directly and clearly in the informed consent and to then provide extra means of maintaining confidentiality or provide the means for the student to access help should they have an emotional reaction to the study. Studies with more risk will change the category status to EXPEDITED or FULL REVIEW status. In these cases, the bar to achieve approval is higher.
The Protection of Pupil Rights Amendment (PPRA) is another regulation that needs to be considered with doing research with minors (individuals under 18 years old). The PPRA specifies under most conditions the right of parents and guardians to inspect any instrument used to collect information concerning the following:
- political affiliations or beliefs of the student or the student’s parent
- mental and psychological problems of the student or the student’s family
- sex behavior or attitudes
- illegal, anti-social, self-incriminating, or demeaning behavior
- critical appraisals of other individuals with whom respondents have close family relationships
- legally recognized privileged or analogous relationships, such as those of lawyers, physicians, and ministers
- religious practices, affiliations, or beliefs of the student or student’s parents
- income other than as required by law to determine program eligibility
Parental/guardian consent is required before such instruments can be used to gather information from a minor. Typically, a researcher must be mindful of this provision and would normally get consent before an instrument would be used. The consent should state that the instrument is available for inspection. Also, if the research is being done in conjunction with a school, the school will likely have a policy related to the PPRA, and the researcher will need to comply with that policy. In cases where these topics are covered, a waiver of consent or documentation of consent cannot be granted by CUHSR.
Guideline Scope and Introduction
Research studies done by Bradley affiliated researchers that involve human subjects must be reviewed and approved by Bradley’s Institutional Review Board (IRB), known at Bradley as the Committee on the Use of Human Subjects in Research (CUHSR). When compensation or incentives are given to research participants, CUHSR works together with the Office of Sponsored Programs and Bradley’s Financial Services to comply with Federal regulations to properly pay participants. When participants are paid by researchers, they must comply with the Bradley University payment procedures and satisfy Internal Revenue Service (IRS) reporting obligations. The personal information obtained when following these guidelines is confidential. A host of ethical issues surround the issue of payment and incentives for research participants. A thorough discussion of those issues can be found at this HHS.gov link.
General Guidelines
- Human subjects participating in research are not paid to provide a service to the university as an employee. Payment to subjects for participation in studies is not considered a benefit but a recruitment incentive.
- Per federal tax law Bradley Financial Services must issue to individuals receiving “miscellaneous income” a 1099 form when either an individual payment or the sum of all payments, regardless of origin, exceeds $600 in a calendar year. Thus, all investigators who are using Bradley funds (any University funds including grant awards) are required to track incentive payments, provide participants with an informed consent document, and notify Financial Services when either an individual payment or cumulative payments approach $600.00 in a calendar year (see procedures below).
- If Financial Services reports funds distributed to an individual participant to the IRS, anonymity of such participant cannot be maintained. The information provided to the IRS does not identify the recipient as a study participant or the purpose of the payment.
- The Principal Investigator (PI) is responsible for informing research participants that the value of any payment they receive for participating in research studies may be taxable income. This is done in the informed consent process. See the last several pages of this document for possible informed-consent language.
- If the participant is not a U.S. Citizen, please refer to the Payment to Non US Citizens sections under special circumstances in this document.
- Remuneration from Bradley University include cash or check, gift cards and gift certificates, electronic gift cards, electronic transfer and value of tangible items.
- Distribution of monetary funds at any amount must be recorded – see the procedures below.
- For payments greater than $100.00, the researcher must contact Financial Services.
- If Bradley students receive compensation for participating in a human subject study, the research team must clearly articulate that receiving such compensation may impact financial aid because the federal government treats remunerations of this type as income. The research team is responsible for sharing the names of student participants with Financial Services and the dollar amount of payments (or value of goods or services) they have received regardless of amount.
Procedures
- Tangible items. Tangible items (not gift cards) that are valued below $50.00 do not need to be reported or recorded. Examples of tangible items include but are not limited to: clothing, mugs, pens, food, etc.
- For other studies when monetary amounts (cash, gift cards or prizes, etc) are distributed in any amount up to and at $100 (or tangible items valued above $50.00 and not more than $100) the Research Participant Receipt form must be filled out. Follow the instructions on the bottom of the form.
- For studies when monetary amounts (cash, checks, gift cards or prizes, etc) are intended to be distributed in any amount beyond $100 the researcher must contact financial services to work out the most appropriate procedures to pay participants. Participants may need to fill out applicable tax forms and provide their social security number before being paid.
- When cash is needed to pay participants, the researcher will need to fill out a Bradley University Advance Request Form.
Special Circumstances
- Personal funds
- Personal funds are out of pocket expenses that will not be reimbursed by any University account.
- Because no University funds are used, the individual researcher does not need to report the payment to Financial Services.
- Because it is up to the recipient of the funds to report payment to the IRS, include a tax statement in your consent form. See the consent language page suggestion on wording in this situation.
- Disburse the funds exactly how you specified in your CUHSR application.
- Non-U.S. Citizen or Non-US National (aka nonresident alien)
- Payroll will withhold a 30% federal tax on any payment to a non-U.S. citizen or national, unless the non-resident can claim a tax treaty benefit.
- The participant must file a Foreign National Information Form (IRS Form 8233) to claim an exemption or reduced tax based upon an applicable treaty.
- Third-party Vendors- If a third-party vendor is used to identify and pay participants, you must provide CUHSR with documentation that the vendor is in compliance with IRS policies if the vendor is not on the approved list.
- Note: Inclusion of a vendor on the list is not an endorsement, but rather it indicates that the vendor is known to be in compliance with IRS policy.
- Approved third-party vendors:1) Amazon Mechanical Turk, 2) Qualtrics
References
- IRS Form 1099-MISC, Miscellaneous Income: https://www.irs.gov/forms-pubs/about-form-1099-misc
- IRS Form 8233, Exemption from Withholding on Compensation for Independent (and Certain Dependent)
- Personal Services of a Nonresident Alien Individual, https://www.irs.gov/forms-pubs/about-form-8233
The Belmont Report serves as our main philosophical and ethical guide in conducting research that involves human subjects. The three main pillars or the “basic ethical principles” of the Belmont report are:
- Respect for persons includes the notion of autonomy to make decisions and protection for classes of individuals who may be vulnerable.
- Beneficence can be summarized into two concepts 1) do no harm and 2) maximize possible benefits and minimize possible harms.
- Justice incorporates the equal distribution of the burdens and benefits of participating in research.
These ethical principles are reflected in policy as they relate to human subject recruitment, consent, and treatment methodology. It should be easy to see that these principles are extended to the language that we use when engaging research participants. It is critical that our language is inclusive and sensitive to the needs and wants of diverse populations. This is especially important given that certain groups have been historically marginalized or harmed by condescending language. Researchers also need to consider that the benefits of research are distributed among individuals of different races, gender identities, ages, sexual orientations, socioeconomic status, abilities, and other personal factors. Historically there has been a lack of diversity in research subjects.
Purpose
The purpose of this guide is to help researchers consider what is the most appropriate language to use that is respective and inclusive. These considerations are as fluid as our modern culture is now. This is our best attempt to give some guidance. These guidelines are to help us be intentionally respectful and to avoid any unintentional harm or offense to individuals. We recommend you embrace this respectful and inclusive language. As CUHSR reviews human subject research we reserve the right to require justification to use certain language and/or ask that you modify language use to meet these guidelines.
Demographics
An area that tends to be troublesome for inclusive and respectful language is the collection of demographic information. The general consideration for collecting any personal information is that it must relate to your research purpose. For example, if race is not an important variable in your study, you should consider not asking for that information. But, we also acknowledge that certain information is collected to assure a diverse group of participants or may be a requirement for a publication. In these cases, you should consider dissociating this information from the individual data collected. Researchers then have to balance two concerns in research, the need for confidentiality and the need for diversity. In the broadest sense, you should always ask yourself how important any demographic information is to your study. If it is not, you should consider eliminating it. On the other hand, you should consider the need for a diverse pool of participants in your study. This can and will differ in every study. In your application, you should make a brief statement of justification regarding the demographics that you include.
To follow the ethical guideline of autonomy, most lists of demographic information should include:
__ Not Listed: ___________
__ Prefer not to say
NOTE: Using “__Other ” is not acceptable as this has a connotation that they are other than normal.
The remainder of the guide will cover specific areas of inclusive and respectful language usage. We encourage you to review the guidelines for inclusive language on our campus produced by the Office of Inclusive Excellence and the Office of Marketing and Communications. This document will go into greater detail and depth (currently being developed).
Ability/Disability
There are a host of terms that are outdated and have been used in pejorative ways. Such terms are “handicapped”, “wheelchair bound”, “the mentally disturbed.” These terms should be replaced with person-first language. Examples would be: instead of saying “disabled persons,” use, “individuals who use wheelchairs”, or “individuals diagnosed with mental illness”. When speaking of people who have specific medical conditions, person-first language should also be used. For example, use “individuals with Parkinson’s disease” instead of “Parkinson’s patients” or “people suffering from Parkinson’s.” When you can, be descriptive with the use of adjectives that state objective facts rather than using labels. For example, instead of stating “stroke victims with walking problems” state, “individuals who walk less than 0.4 m/sec secondary to hemiplegia.” This language is more descriptive and avoids calling people victims and qualifying their ability to walk as a problem. Another example would be instead of referring to someone as “low functioning,” state, “an individual in need of support with______.”
Some communities of persons with disabilities prefer to be identified by their disability. For example, some individuals prefer to be referred to as “Blind” rather than “individuals with visual impairments.” Some individuals prefer “Deaf” as to “hearing impaired” because they identify strongly with the deaf community. It is incumbent upon the researcher to understand these kinds of language idiosyncrasies before engaging individuals as research participants.
Age, Physical Characteristics
When referring to age avoid using terms that may reinforce stereotypes. For example, you should avoid terms like seniors, the elderly, or the aged. Better terms would be older persons, older adults, or individuals over the age of 65. When constructing surveys consider using groups of ages that make sense for your research. Rarely would it be necessary to ask for a specific birthday. Even asking for a specific age may run the risk of re-identification.
Terms describing physical characteristics could inadvertently be condescending. Obesity is a term that is used in medicine and used in our general culture that could carry negative stereotypes. Instead of stating “obese persons” consider using terms that describe the objective facts about the individual such as “individuals with a BMI between 30 and 35.” Instead of saying “a group of anorexics” consider stating “a group of individuals 20% below their ideal weight for good health”.
Sex, Gender/Gender Identity, and Sexual Orientation
Unfortunately in the past, the terms sex, gender, and sexual orientation have been confused and used interchangeably. Each of these terms has a specific meaning and will have a specific use in different types of research. As with all the questions in this area, securing confidentiality or anonymity is essential. Accidental breaches of confidentiality or re-identification could have unintended consequences and harm to research subjects.
Sex generally refers to the biological sex assigned at birth. Asking about one’s sex could be necessary for biomedical research in which there could be a difference in physiology or biomechanics between males and females that may have a significant impact on research outcomes. Because asking about one’s sex is akin to asking about medical information, it should be used only when necessary.
Typically the following would be acceptable:
Indicate your sex assigned at birth:
____Female
____Male
____Intersex
____Not Listed: ___________
____Prefer not to say
Because there is some ambiguity in some cases when considering biological sex, it is best not to ask for one’s biological sex. Depending on your research area, there may be some specific language that is used in your field. For example, inclusive language used by pelvic health practitioners is: “individuals with vulvas” and “individuals with penises.” In some practices, the term “individuals who are pregnant” is used instead of “pregnant women.”
Gender is a social construct of specific roles and identities of individuals. In culture today these identities extend beyond the traditional designation of woman and man. When asking for gender, the best practice would be to ask: “Please state your preferred gender/gender identity”.
The following would be the least you should ask to be minimally inclusive:
____ Woman
____ Man
____ Nonbinary person
____ Transgender person
____ Not Listed: ___________
____ Prefer not to say
There are other designations such as gender fluid, gender questioning, and genderqueer. Depending on the nature of your research you could include several more appropriate adjectives to select for one’s gender identity.
Sexual orientation could be an important variable in one’s research. Again if you are asking about sexual orientation, it should be justified in your application. Terms to use related to sexual orientation remain ambiguous. However, we recommend the following acceptable terms as minimally inclusive: would be acceptable to be minimally inclusive.
Please state the sexual orientation that best describes you:
____Bisexual
____Gay/Lesbian
____Straight
____Asexual
____Pansexual
____Not Listed: ___________
____Prefer not to say
Generally, use gender-neutral language such as Chairperson instead of Chairman. Use neutral pronouns such as they, theirs, them, rather than he/she, him/her, his/hers.
Race, Ethnicity, Religion, and Nationality
Categorizing individuals by race, ethnicity, religion, or nationality can be complicated. One category or even several categories will never capture the breadth and depth of the complexity of individuals’ backgrounds, beliefs, and behaviors. However, research using precise categories can help us gain insight into groups of people. This may be especially important to understand if certain groups are marginalized or treated differently revealing disparities among groups. Thus, researchers should be as accurate and descriptive as possible when categorizing groups.
Race and ethnicity have distinct meanings, but they are often combined into one question or concept since both are social constructs without a basis in biology. Race refers to similar physical characteristics deemed important to society. Ethnicity refers to shared cultural features such as language and ancestry. Religion is a cultural group of beliefs and practices that typically, but not always, involve worship of a deity and/or acknowledge a spiritual dimension. Nationality or Country of Origin simply refers to the geographical place of upbringing and/or national allegiance.
Though there can be considerable overlap between these concepts, the researcher should be clear as to which category they are gathering data. While race is a social-cultural construct, an individual ancestry could be important in some biomedical research as individuals within an ancestral line may have certain genetic risk factors and predispositions for diseases or illnesses. Biomedical researchers may consider asking: “Which term best describes your ancestral lineage going back two generations,” using terminologies, such as Asian descent, European descent, or African descent, to ensure they are considering possible traits of participants’ ancestral lineage.
The researcher should also consider if the racial/ethnic data they are collecting is being compared with racial/ethnic groupings from the government. In this case, they should reference the governmental standard. Most inclusive survey research will allow for mixed racial designation. The National Institute of Health (NIH) combines race and ethnicity into the following categories:
- “American Indian or Alaska Native. A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment.
- A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam.
- Black or African American. A person having origins in any of the black racial groups of Africa. Terms such as “Haitian” or “Negro” can be used in addition to “Black or African American.”
- Hispanic or Latino. A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, “Spanish origin,” can be used in addition to “Hispanic or Latino.”
- Native Hawaiian or other Pacific Islander. A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands.
- A person having origins in any of the original peoples of Europe, the Middle East, or North Africa.”
Please note, in the above list the categories are alphabetically. This is an acceptable way to list these groups to avoid any unintentional bias. A researcher should consider the following statement, “Select the racial/ethnic group you identify with the most (listed in alphabetical order)”.
Ethnic groups can be broad and varied. Researchers need to explore and be familiar with the ethnic groups with whom they work and the most appropriate language to use regarding the same. Hispanic and Latino are common ethnic groupings in the Western Hemisphere. Latina and Latinx are similar designations but with some controversy. The designation “European American” is more frequently being used with “White” as some individuals do not want to be associated with the cultural negative connotation of the term “White.”
When asking about race, consider using a phrase such as:
“Which racial/ethnic group(s) do you identify with the most? (Choose all that apply.)”
Within your list of options, also include:
____Not Listed: ___________
____Prefer not to say
This language allows for self-determination rather than being forced into a category. Another less descriptive category that is acceptable to use is BIPOC [Black and Indigenous People of Color].
For an in-depth explanation of this topic, we recommend you read the following: Updated Guidance on the Reporting of Race and Ethnicity in Medical and Science Journals written in the Journal of the American Medical Association. For a more nuanced treatment of the language for race and ethnicity, see the Bradley University Guide on Inclusive Language. As well, review guidelines that are most acceptable to your professional organization and professional journals.
Religious affiliation may be an important variable in social behavioral research as religious beliefs can shape an individual’s worldview. Research protocols need to be careful to include appropriate religious designations with appropriate terminology, being aware the major religions have different subcategories that reflect various beliefs.
To be inclusive we recommend designation of the following:
____No religious affiliation
____Atheist/Agnostic
____Not Listed: ___________
____Prefer not to say
In some cases, a breach of confidentiality can be critical where an acknowledgment of a religious affiliation could lead to persecution.
Nationality can also be a variable to help researchers understand a people group. Considerations need to be made for different variations regarding nationality. The following are examples: Current nation of residence, country of origin or upbringing, Parents’ Country of Origin, and Languages spoken in the home as a child. As well, “immigrants” or “undocumented immigrants” are the preferred language over “aliens”.
Low-income Individuals
A negative connotation is associated with people when using inappropriate language describing socioeconomic status such, as “the poor”, “the homeless,” or “inner city.” Instead, use person-first language, such as: a person experiencing homelessness, or a family receiving temporary assistance. Researchers could also use actual income levels rather than using terms, such as: “low income”, “low socioeconomic status,” or “middle class.”
Dr. Andrew J (AJ) Strubhar CUHSR Chair (2026)
Department of Physical Therapy and Health Science
Dr. Karin Smith (2028) CUHSR Associate Chair (2028)
Interitem Chair Aug 18 – Jan 2, 2026
Department of Nursing
Dr. DeMaris Montgomery (2026)
Department of Psychology
Dr. Deitra Kuester (2026)
Department of Education and Health Science
Dr. Lizabeth Crawford (2026)
Department of Sociology
Dr. Kalyani Nair (2027)
College of Engineering
Mindy Reeter (2028)
University of Illinois College of Medicine at Peoria (UICOMP)
Community Member and Non-Scientist
Joseph Harris (2027)
Department of Psychology
David Dominguese (2027)
Department of Physical Therapy and Health Science
On May 11, 2023, Illinois has aligned with federal government’s decision to end the COVID 19 national public health emergency. For research protocols requiring in-person interaction should be sensitive to any level of community outbreak and be prepared to deploy social distancing and face coverings in accordance with the local public health guidelines. Protocols within health care facilities should align their infection control procedures with that facility. Additionally, best practices should still be considered such as ensuring that hand sanitizer and handwashing facilities are readily available and encouraged and establishing rigorous disinfecting protocols for study equipment or manipulatives.
Investigators with new research protocols that involve in-person contact with populations vulnerable to infection should still include in their application how they are applying the restrictions and all the steps they are taking to mitigate COVID-19 or any pathogen exposure.
- August 29, 2025
- September 26, 2025
- October 24, 2025
- November 21, 2025
- December 5, 2025
- January 23, 2026
- February 27, 2026
- March 27, 2026
- April 24, 2026
- May 8, 2026
- Bradley Hall Room 18
- srast@bradley.edu
- (309) 677-3877